ORA - Oxford University Research Archive

1 - 10 of 10

1

Journal article

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial

Wajja, A, Kizito, D, Nassanga, B, et al.
2017-05-04

2

Journal article

Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.

Zhang, Y, Xu, J, Levin, J, et al.
2004-04-05

3

Journal article

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.

Kiwuwa-Muyingo, S, Walker, AS, Oja, H, et al.
2012-05-05

4

Journal article

Clustering based on adherence data.

Kiwuwa-Muyingo, S, Oja, H, Walker, SA, et al.
2011-01-01

5

Journal article

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.

Kiwuwa-Muyingo, S, Oja, H, Walker, A, et al.
2013-01-01

6

Journal article

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.

Muyingo, SK, Walker, AS, Reid, A, et al.
2008-08-05

7

Journal article

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

Mugyenyi, P, Walker, AS, Hakim, J, et al.
2010-01-05

8

Journal article

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A

Wajja, A, Namutebi, M, Apule, B, et al.
2018-09-19

9

Journal article

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.

Wajja, A, Namutebi, M, Apule, B, et al.
2018-01-15

10

Journal article

Eighth International Chorea–Acanthocytosis Symposium: summary of workshop discussion and action Points

Pappas, SS, Bonifacino, J, Danek, A, et al.
2017-02-15

TO TOP